Tpg Gp A, LLC Rallybio Corp Transaction History
Tpg Gp A, LLC
- $1.66 Billion
- Q2 2025
A detailed history of Tpg Gp A, LLC transactions in Rallybio Corp stock. As of the latest transaction made, Tpg Gp A, LLC holds 3,028,414 shares of RLYB stock, worth $1.73 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,028,414
Previous 3,028,414
-0.0%
Holding current value
$1.73 Million
Previous $1.97 Million
47.71%
% of portfolio
0.06%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
49Shares Held
31.6MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$2.39 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$2.07 Million0.42% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$2.07 Million0.83% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$1.88 Million3.34% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA2.4MShares$1.37 Million0.77% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $18.3M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...